| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-107 |
Sentence |
denotes |
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. |
| T1 |
0-107 |
Sentence |
denotes |
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. |
| T2 |
108-248 |
Sentence |
denotes |
Eosinophils and neutrophils are closely related, terminally differentiated cells that in vitro undergo constitutive cell death by apoptosis. |
| T2 |
108-248 |
Sentence |
denotes |
Eosinophils and neutrophils are closely related, terminally differentiated cells that in vitro undergo constitutive cell death by apoptosis. |
| T3 |
249-349 |
Sentence |
denotes |
The onset of apoptosis in both cell types can be delayed by hemopoietins and inflammatory mediators. |
| T3 |
249-349 |
Sentence |
denotes |
The onset of apoptosis in both cell types can be delayed by hemopoietins and inflammatory mediators. |
| T4 |
350-608 |
Sentence |
denotes |
Although there have been a number of reports demonstrating that glucocorticoids (in particular dexamethasone) antagonize the eosinophil life-prolonging effects of hemopoietins, direct effects of dexamethasone on eosinophil apoptosis have not been documented. |
| T4 |
350-608 |
Sentence |
denotes |
Although there have been a number of reports demonstrating that glucocorticoids (in particular dexamethasone) antagonize the eosinophil life-prolonging effects of hemopoietins, direct effects of dexamethasone on eosinophil apoptosis have not been documented. |
| T5 |
609-817 |
Sentence |
denotes |
In this study we examined the direct effects of glucocorticoids on eosinophil and neutrophil apoptosis in light of their common therapeutic use as anti-inflammatory and anti-allergic/hypereosinophilic agents. |
| T5 |
609-817 |
Sentence |
denotes |
In this study we examined the direct effects of glucocorticoids on eosinophil and neutrophil apoptosis in light of their common therapeutic use as anti-inflammatory and anti-allergic/hypereosinophilic agents. |
| T6 |
818-890 |
Sentence |
denotes |
We found that treatment with dexamethasone induced eosinophil apoptosis. |
| T6 |
818-890 |
Sentence |
denotes |
We found that treatment with dexamethasone induced eosinophil apoptosis. |
| T7 |
891-965 |
Sentence |
denotes |
In contrast, dexamethasone was a potent inhibitor of neutrophil apoptosis. |
| T7 |
891-965 |
Sentence |
denotes |
In contrast, dexamethasone was a potent inhibitor of neutrophil apoptosis. |
| T8 |
966-1136 |
Sentence |
denotes |
The effect of dexamethasone on both cell types was mediated through the glucocorticoid receptor, i.e., it was abolished by the glucocorticoid receptor antagonist RU38486. |
| T8 |
966-1136 |
Sentence |
denotes |
The effect of dexamethasone on both cell types was mediated through the glucocorticoid receptor, i.e., it was abolished by the glucocorticoid receptor antagonist RU38486. |
| T9 |
1137-1458 |
Sentence |
denotes |
This is the first description of an agent that promotes eosinophil apoptosis while inhibiting neutrophil apoptosis, and thus presents a novel approach to the study of control of apoptosis in these closely related cell types as well as increases our understanding of the clinical action of glucocorticoids in inflammation. |
| T9 |
1137-1458 |
Sentence |
denotes |
This is the first description of an agent that promotes eosinophil apoptosis while inhibiting neutrophil apoptosis, and thus presents a novel approach to the study of control of apoptosis in these closely related cell types as well as increases our understanding of the clinical action of glucocorticoids in inflammation. |